CASI Stock Summary and Trading Ideas (Casi Pharmaceuticals - | NASDAQ:CASI)

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Casi Pharmaceuticals - trades on the NASDAQ stock market under the symbol CASI.

As of February 23, 2026, CASI stock price declined to $0.76 with 44,441 million shares trading.

CASI has a beta of 0.53, meaning it tends to be less sensitive to market movements. CASI has a correlation of 0.01 to the broad based SPY ETF.

CASI has a market cap of $11.72 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CASI traded as high as $8.48 and as low as $.74.

CASI has underperformed the market in the last year with a price return of -69.1% while the SPY ETF gained +15.0%. CASI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.5% and -16.4%, respectively, while the SPY returned +3.8% and -1.7%, respectively.

CASI support price is $.69 and resistance is $.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CASI shares will trade within this expected range on the day.